Halozyme Investor Update June 2024

Loading viewer...

investor_presentation

Format: PDF investor_presentation

Halozyme presents its June 2024 investor update covering financial guidance through 2028, ENHANZE® drug delivery technology patent developments, and collaboration expansion plans. The presentation outlines expectations for revenue growth, adjusted EBITDA margins, and royalty revenues from partner commercialization efforts.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Halozyme

View all →

Halozyme 2022 Corporate Presentation | ENHANZE Drug Delivery Platform

investor_presentation

25 Pages

Halozyme Corporate Presentation 2022

investor_presentation

Similar investor_presentations from other companies

Browse all →

First Helium Investor Presentation 2022

investor_presentation

32 Pages

FIRST HELIUM

Visa Investor Presentation — July 2022

investor_presentation